Literature DB >> 25153400

Diagnostic testing for a high-grade inflammation: parameter dynamics and novel markers.

Christina Hoffmann, Peter Hoffmann, Mathias Zimmermann.   

Abstract

BACKGROUND: The timely detection of severe inflammatory conditions is of great importance for early therapy initiation and the patient's prognosis. The complex humoral and cellular processes involved in inflammation offer many opportunities for diagnostic testing, which are still unused in clinical practice. We investigated the dynamics of four established and two novel potential markers during the onset and resolution of a high-grade inflammation.
METHODS: We retrospectively analyzed C-reactive protein and procalcitonin concentrations, leukocyte and thrombocyte counts, granularity index, and δ-hemoglobin measured in peripheral blood samples of patients undergoing inflammation diagnostics between September 2010 and November 2010. Data from a consecutive sample of 53,968 patients were available.
RESULTS: Trajectories for the parameters' dynamics during the onset and resolution of a high-grade inflammation were calculated with a locally weighted scatter plot smoothing method. The leukocyte count trajectories did not exceed the reference range.
CONCLUSIONS: We were able to elucidate the parameter dynamics with time coordinates rounded to the nearest hour and a follow-up of 168 h.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25153400     DOI: 10.1515/cclm-2014-0482

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response.

Authors:  Aleksandar R Zivkovic; Jochen Bender; Thorsten Brenner; Stefan Hofer; Karsten Schmidt
Journal:  J Inflamm Res       Date:  2016-11-18

2.  Bedside-measurement of serum cholinesterase activity predicts patient morbidity and length of the intensive care unit stay following major traumatic injury.

Authors:  Aleksandar R Zivkovic; Karsten Schmidt; Thomas Stein; Matthias Münzberg; Thorsten Brenner; Markus A Weigand; Stefan Kleinschmidt; Stefan Hofer
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.